MedTrace Logo

Hair Cortisol in Asthma or Allergic Rhinitis Treated With Topical Corticosteroids

NCT01839851 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2014-03-11

No results posted yet for this study

Summary

The purpose of this study is to prospectively examine the relation between topical corticosteroid use and hair cortisol concentration, among patients with moderate persistent asthma or allergic rhinitis. The investigators hypothesize that patients with asthma or allergic rhinitis treated with topical corticosteroids (i.e. inhaled corticosteroids (ICS) or intranasal glucocorticoids (INGC)) have higher levels of hair cortisol after 3 months of treatment than during the 3 months prior to initiation of treatment.

Conditions

Interventions

DRUG

Treatment with any inhaled corticosteroid

Use of any inhaled corticosteroid (daily frequency and dose will be registered)

DRUG

Treatment with any intranasal glucocorticoid

Use of any inhaled intranasal glucocorticoid (daily dose and frequency will be registered)

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Eilon Krashin, MD · Meir Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01839851 on ClinicalTrials.gov